Yang SS - Search Results

1

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.

Chang TS, Huang CF, Kuo HT, Lo CC, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Wang SJ, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Chen CY, Tseng KC, Hung CH, Yu ML. Chang TS, et al. Among authors: yang cc, yang ss. Hepatol Int. 2023 Jun;17(3):550-561. doi: 10.1007/s12072-023-10506-z. Epub 2023 Mar 27. Hepatol Int. 2023. PMID: 36973633 Free PMC article.

2

Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin.

Yang SS, Lai MY, Chen DS, Chen GH, Kao JH. Yang SS, et al. Liver Int. 2003 Dec;23(6):426-33. doi: 10.1111/j.1478-3231.2003.00875.x. Liver Int. 2003. PMID: 14986817

3

Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.

Lu SN, Su WW, Yang SS, Chang TT, Cheng KS, Wu JC, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Chen CH. Lu SN, et al. Among authors: yang ss. Int J Cancer. 2006 Oct 15;119(8):1946-52. doi: 10.1002/ijc.22045. Int J Cancer. 2006. PMID: 16708389 Free article.

4

Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients.

Chen CH, Chang TT, Cheng KS, Su WW, Yang SS, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Lu SN. Chen CH, et al. Among authors: yang ss. Liver Int. 2006 Sep;26(7):766-73. doi: 10.1111/j.1478-3231.2006.01309.x. Liver Int. 2006. PMID: 16911457

5

Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan.

Chen CH, Su WW, Yang SS, Chang TT, Cheng KS, Lin HH, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Lu SN. Chen CH, et al. Among authors: yang ss. J Gastroenterol Hepatol. 2006 Oct;21(10):1561-6. doi: 10.1111/j.1440-1746.2006.04425.x. J Gastroenterol Hepatol. 2006. PMID: 16928217

6

Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.

Yang SS, Fu LS, Chang CS, Yeh HZ, Chen GH, Kao JH. Yang SS, et al. J Gastroenterol Hepatol. 2006 Dec;21(12):1789-93. doi: 10.1111/j.1440-1746.2006.04677.x. J Gastroenterol Hepatol. 2006. PMID: 17074015

7

Factors associated with quality of life in chronic hepatitis C patients who received interferon plus ribavirin therapy.

Chang SC, Ko WS, Wu SS, Peng CY, Yang SS. Chang SC, et al. Among authors: yang ss. J Formos Med Assoc. 2008 Jun;107(6):454-62. doi: 10.1016/S0929-6646(08)60153-9. J Formos Med Assoc. 2008. PMID: 18583216 Free article.

8

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

Liu CH, Liu CJ, Lin CL, Liang CC, Hsu SJ, Yang SS, Hsu CS, Tseng TC, Wang CC, Lai MY, Chen JH, Chen PJ, Chen DS, Kao JH. Liu CH, et al. Among authors: yang ss. Clin Infect Dis. 2008 Nov 15;47(10):1260-9. doi: 10.1086/592579. Clin Infect Dis. 2008. PMID: 18834319 Clinical Trial.

9

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage.

Liu CJ, Lee PH, Lin DY, Wu CC, Jeng LB, Lin PW, Mok KT, Lee WC, Yeh HZ, Ho MC, Yang SS, Lee CC, Yu MC, Hu RH, Peng CY, Lai KL, Chang SS, Chen PJ. Liu CJ, et al. Among authors: yang ss. J Hepatol. 2009 May;50(5):958-68. doi: 10.1016/j.jhep.2008.12.023. Epub 2009 Feb 15. J Hepatol. 2009. PMID: 19303160 Clinical Trial.

10

Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas.

Su WW, Chen CH, Lin HH, Yang SS, Chang TT, Cheng KS, Wu JC, Wu SS, Lee CM, Changchien CS, Chen CJ, Sheu JC, Chen DS, Lu SN. Su WW, et al. Among authors: yang ss. Hepatol Int. 2009 Dec;3(4):537-43. doi: 10.1007/s12072-009-9146-x. Epub 2009 Aug 7. Hepatol Int. 2009. PMID: 19669239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,419 results

Search Page